Mersana Therapeutics, Inc. Operating Lease Right-of-Use Assets
Mersana Therapeutics, Inc. had Operating Lease Right-of-Use Assets of $2.04 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2025-11-14
- 2025-09-30: Operating Lease, Right-of-Use Asset $2.04M.
- 2025-06-30: Operating Lease, Right-of-Use Asset $2.90M.
- 2025-03-31: Operating Lease, Right-of-Use Asset $3.74M.
- 2024-12-31: Operating Lease, Right-of-Use Asset $4.58M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-09-30 | $2.04M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $2.90M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $3.74M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $4.58M 10-Q · filed 2025-11-14 |
| 2024-09-30 | $5.39M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $6.18M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $6.95M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $7.69M 10-K · filed 2025-03-03 |
| 2023-09-30 | $8.42M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $9.13M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $9.81M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $10.47M 10-K · filed 2024-02-28 |
| 2022-09-30 | $11.06M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $11.69M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $12.00M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $12.89M 10-K · filed 2023-02-28 |
| 2021-09-30 | $13.17M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $13.75M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $10.52M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $10.94M 10-K · filed 2022-02-28 |
| 2020-09-30 | $11.34M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $11.74M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $12.13M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $2.60M 10-K · filed 2021-02-26 |
| 2019-09-30 | $3.06M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $3.51M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $3.94M 10-Q · filed 2019-05-09 |